EGFR ADC
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Prospective, Open-label, Multi-cohort Study of Becotatug Vedotin With Tislelizumab and Chemotherapy in Esophageal Squamous Cell Carcinoma - Phase 2 (NCT07531979) | Tianjin Medical University Cancer Institute and Hospital | 2026-04-01 |
Track EGFR ADC automatically
Every clearance here is in the API, with alerts when new ones post.